MIT Technology Review @techreview
Supplies of Pfizer's covid-19 vaccine are likely to be limited until well into 2021, meaning most people won’t be able to get it anytime soon. In the below story from August, we look at the race among countries to secure a supply for themselves first. https://t.co/B9S9F295jl — PolitiTweet.org